•  
  •  
 

Abstract

Introduction. The presence of ACE gene polymorphism is expected to have a role in cardiovascular diseases, including coronary slow flow phenomenon (CSFP). Angiotensin converting enzyme (ACE) gene polymorphism also plays an essential role in increasing angiotensin II levels. Therefore, this study aimed to analyze the effect of angiotensin-converting enzyme gene polymorphism and angiotensin II levels in the coronary slow flow phenomenon in Mohammad Hoesin General Hospital Palembang. Methods. This case-control study was started from July 2019 to July 2020 at RSMH Palembang with 32 subjects for each case (CSFP patients) and the control group (non-CSF patients). This study used a pair of primers and onetimed PCR to detect ACE gene polymorphism. Genetic analysis was carried out in the Biotechnology Laboratory Faculty of Medicine, Universitas Sriwijaya. Statistical analysis was performed using the Spearman correlation test. Results. There were 17 subjects with II genotypes (53.1%), 14 subjects with ID genotypes (43.8%), and 1 subject with DD genotypes (3.1 %) in the CSFP group. While in the non-CSFP group, there were 11 subjects with II genotypes (34.4%), 13 subjects with ID genotypes (42.2%), and 9 subjects with DD genotypes (14.1%). The median value of angiotensin II levels in CSFP and Non-CSF group was 58 pg/mL and 32.8 pg/mL, respectively. The results of the analysis showed that there was an effect of angiotensin II levels on the incidence of CSFP (p=0.001). Further analysis showed that there was a correlation between angiotensin II levels and the I/D 287 bp alu repetitive sequence polymorphism in the intron 16 ACE gene (p=0.030, r=0.822). Conclusions. There was a correlation between I/D 287 bp alu repetitive sequence polymorphism in the intron 16 ACE gene and angiotensin II levels in the coronary slow flow phenomenon at Mohammad Hoesin General Hospital Palembang.

References

1. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E, Cleveland O. Angina pectoris and slow flow velocity of dyein coronary arteries-A new angiograpbic finding. Am Heart J. 1972;84(1):66-71. 2. Ghanie A, Indrajaya T, Ali Z, Partan RU, Saleh MI. Molecular diagnostic marker, “ace polymorphism gen” inpatient of slow coronary flow syndrome in Mohammad Hoesin Hospital Palembang. Acta Med. 2017;2(2):1-7. 3. Dogan A, Oylumlu M, Kilit C, Ozgeyik M. ST elevation myocardia infarction caused by coronary slow flow: Case report and brief review of the literature. Int J Cardiovasc Acad. 2016;2:52-5. 4. Wang X, Geng LL, Nie SP. Coronary slow flow phenomenon: a local or systemic disease? Med Hypotheses. 2010;75:334-7. 5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. AN insertion/deletion polymorphism in the angiotensin I-converting enzyme gen accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343-6. 6. Yalcin A, Kalay N, Caglayan A, Caglayan A, Ibrahim O, Duran M, et al. The relationship between slow coronary flow and angiotensin Converting Enzym and ATIIR1. J Natl Med Assoc. 2009;101(1):40-5. 7. Tanriverdi H, Evrengul H, Mergen H. Early sign of atherosclerosis in slow coronary slow flow and relationship with angiotensin converting enzyme I/D polymorphism. Heart Vessels. 2007;22:1-8. 8. Tsukada K, Ishimitsu T, Tsuchiya N, Horinaka S, Matsuoka H. Angiotensin converting enzyme gene polymorphism and cardiovascular endocrine system in coronary angiography patients. Jpn Heart J. 1997;38:799-810. 9. Sekuri C, Cam FS, Ercan E, Tengiz I, Sagcan A, Eser E, et al. Reninangiotensin system gene polymorphism and premature coronary heart disease. J Renin Angiotensin Aldosterone Syst. 2005;6(1):38- 42. 10. Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M, Schechter E. Coronary slow flow--prevalence and clinical correlations. Circ J. 2012;76(4):936-42. 11. PERKI. Panduan tatalaksana dislipidemia 2017 [Internet]. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia; 2017 [accessed 28th April 2019]. Available from: jki.or.id 12. Elamgary AA, Abdelhalim AA, Arafa ME, Baghdady YM. Anxiety and depression relationship with coronary slow flow. PLoS One. 2019;14(9):e0221918 . 13. Sanghvi S, Mathur R, Baroopal A, Kumar A. Clinical, demographic, risk factor and angiographic profile of coronary slow flow phenomenon: A single centre experience. Indian Heart J. 2018;70:s290-4. 14. Mukhopadhyay S, Kumar M, Yusuf J, Gupta VK, Tyagi S. Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study. Indian Heart J. 2018;70(3):405-9. 15. Ghaffari S, Tajlil A, Aslanabadi N, Separkam A, Sohrabi B, Saeidi G, et al. Clinical and laboratory predictors of coronary slow flow in coronary angiography. Perfusion 2017;32(1):13-9. 16. PERKENI. Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia 2015. Jakarta: PERKENI; 2015. hal.1-93. 17. Dai S, Ding M, Liang N, Li Z, Li D, Guan L, et al. Associations of ACE I/D polymorphism with the levels of ACE, kallikrein, angiotensin II, and interleukin-6 in STEMI patients. Sci Rep. 2019;9:19719. 18. Becari C, Oliveira EB, Salgado MCO. Alternative pathways for angiotensin II generation in the cardiovascular system. Braz J Med Biol Res. 2011;44:914-9. 19. Santos CF, Paula CA, Salgado MC, Oliveira EB. Kinetic characterization and inhibition of the rat MAB elastase-2, an angiotensin I-converting serine protease. Can J Physiol Pharmacol. 2002;80:42-7. 20. McDonald JE, Padmanabhan N, Petrie MC, Hillier C, Connell JM, McMurray JJ. Vasoconstrictor eff ect of the angiotensin-converting enzyme-resistant, chymase-specifi c substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: In vivo demonstration of non-ACE production of angiotensin II in humans. Circulation. 2001;104:1805-8. 21. Richard V, Hurel-Merle S, Scalbert E, Ferry G, Lallemand F, Bessou JP, et al. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated hu- man arteries. Circulation. 2001;104: 750-2. 22. Santos CF, Caprio MA, Oliveira EB, Salgado MC, Schippers DN, Munzenmaier DH, et al. Functional role, cellular source, and tissue distribution of rat elastase-2, an angiotensin II- forming enzyme. Am J Physiol Heart Circ Physiol. 2003;285:775-83. 23. Becari C, Sivieri DO Jr, Santos CF, Moyses MK, Oliveira EB, Salgado MC. Role of elastase-2 as an angiotensin II-forming enzyme in rat carotid artery. J Cardiovasc Pharmacol. 2005;46:498- 504. 24. Indrajaya T. Analisis polimorfisme gen ACE, aktivitas ACE dan kadar aldosterone serum penderita stroke non hemoragik dengan riwayat hipertensi pada populasi di Palembang. Acta Medica. 2011;43(3):152-7.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.